Zimbabwe Receives 2 Million More Vaccine Dosses From China
A total 2 million more doses of the Sinovac vaccine have arrived from China. By Michael Gwarisa Speaking soon after arrival of vaccines, Finance and Economic Development Minister, Professor Mthuli Ncube said over 4 Million doses of vaccines have been received in the country every since the Vaccination program commenced in February this year. The
Read More
Zimbabwe Should Rethink Vaccine Deployment Strategy
ZIMBABWE has been urged to re-look its national vaccination distribution strategy in order to increase uptake and move close towards vaccinating at least 60 percent of the population. By Michael Gwarisa The country commenced vaccinating its citizens in March 2021 following a delivery of the Sinopharm doses from the Republic of China. Even though at
Read More
Rejecting Johnson & Johnson Vaccine Unscientific
THE decision by the Zimbabwen government to reject the Johnson & Johnson vaccine on the grounds of safety and storage issues might not be the in the best interests of citizens and lacks the scientific evidence to back the reasons up, a leading local Immunologist has said. By Michael Gwarisa This comes after revelations that
Read MoreZimbabweans Risk Incomplete Vaccination
THE prevailing shortages of first doses of vaccines being administered in Zimbabwe could result in majority of citizens being partially vaccinated if something is not done urgently, a Public Health Expert has warned. By Tanaka Moyo There have been widespread and confirmed reports of shortages of first dosses of the Sinopharm and Sinovac vaccines especially
Read More
Zim to receive more 500 000 vaccine doses
ZIMBABWE is set to receive 500 000 Sinopharm vaccine doses which were procured from China in June to boost the vaccination programme which is currently underway in the country. By Patricia Mashiri Speaking during a Cabinet briefing Senator Monica Mutsvagwa, the Minister of Information, Publicity and Broadcasting Services said they were expecting the vaccines in
Read More
#TalkingCOVIDWithDrGrant: Different Variants, Similar Control Strategies
THE Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative virus for the disease better known as COVID-19. It belongs broadly to a class of viruses known as coronaviruses, and people are more familiar with the previous SARS and MARS outbreaks. None of these ever got to the scale of the current COVID-19 pandemic.
Read More
#BREAKING: WHO Approves Sinopharm Vaccine For Emergency Use
WHO today listed the Sinopharm COVID-19 vaccine for emergency use, giving the green light for this vaccine to be rolled out globally. The Sinopharm vaccine is produced by Beijing Bio-Institute of Biological Products Co Ltd, subsidiary of China National Biotec Group (CNBG). WHO Communication “The addition of this vaccine has the potential to rapidly accelerate
Read More
Sinopharm Suits Zimbabwe’s Cold Chain Capacity
UNLIKE other COVID-19 vaccines that were developed using the Messenger Ribonucleic Acids (M-RNA) technology, vaccines manufactured using a killed/inactivated virus such as the Sinopharm, Sinovac and COVAXIN currently being administered in Zimbabwe do not require expensive subzero cold-chain infrastructure. By Michael Gwarisa The messenger RNA technology was deployed in the Pfizer, Mordena and other vaccines,
Read More
Zim COVID-19 Epidemic Curve Flattening – Dr Grant
LOCAL Public Health Expert and Epidemiologist, Dr Grant Murewanhema has hinted that Zimbabwe’s epidemic curve was at the verge of flattening even though clustered sections of infections were still reported at community level. By Michael Gwarisa An epidemic curve, also known as an epi curve or epidemiological curve, is a statistical chart used to visualize
Read More
#LongReadAhead: Vaccines Efficacy And Effectiveness Explained
By Michael Gwarisa THE arrival of the coronavirus on our shores has to a larger extent planted an appetite for reading and commenting around health-related issues even amongst non-medical people. All of a sudden everyone is now a public health or medical analyst and this is largely due to information gaps present in our communities. The World Health
Read More